Safety of endoscopic interventions in patients with thrombocytopenia

Somashekar G. Krishna, Bhavana B. Rao, Selvi Thirumurthi, Jeffrey H. Lee, Srinivas Ramireddy, Michele Guindani, William A. Ross

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background The risk of endoscopic interventions in thrombocytopenia has received little attention in the medical literature. Objective The aim of this study was to assess the safety of endoscopic interventions including evaluation of GI bleeding (GIB) in patients with thrombocytopenia. Design and Setting Retrospective study, tertiary oncology center. Patients and Intervention Review of consecutive endoscopies with preprocedure platelet counts (PCs) of 75 × 103/μL or lower. Main Outcome Measurements Risk of bleeding with routine endoscopic interventions and transfusion requirement after evaluation of GIB. Results A total of 617 (351 upper, 266 lower [90 colonoscopies]) endoscopies were performed in 395 patients. Forceps-biopsy specimens were obtained in 398 endoscopies (mean ± standard deviation [SD] PC: 38.21 ± 11.7 × 103/μL) and 45 polypectomies were performed in 17 endoscopies (mean ± SD PC: 39.65 ± 8.53 × 10 3/μL). The risk of bleeding was 1.5% (6 of 398 endoscopies) at the biopsy site and 4% (2 of 45 polypectomies) at the polypectomy site. Active GIB (mean ± SD PC: 32.85 ± 4.0 × 103/μL) was observed in 68 (11% of 617) endoscopies and intervention (mean ± SD PC: 33.68 ± 4.6 × 103/μL) was performed in 41 procedures. Together, angiodysplasias and ulcers were the most common etiology (51.2% of 41). Hemostasis was achieved in 39 (95.1% of 41) procedures. Comparison of blood transfusions ± 3 days of successful therapy showed a 52% reduction (P <.001). By multivariate analysis, a higher aggregate blood transfusion 3 days preceding endoscopy (odds ratio 1.32; 95% confidence interval, 1.16-1.50; P <.001) predicted endoscopic findings of active GIB. Limitations Retrospective design, single center. Conclusions In the largest endoscopic experience reported in thrombocytopenic patients (Common Terminology Criteria for Adverse Events grade 3 or lower), bleeding caused by standard forceps biopsy and polypectomy (≤10 mm) was minor and easily controlled. Endoscopic therapy for GIB is safe and significantly reduces the packed red blood cell requirement and should be considered in patients with thrombocytopenia in the setting of an appropriate transfusion strategy.

Original languageEnglish (US)
Pages (from-to)425-434
Number of pages10
JournalGastrointestinal endoscopy
Volume80
Issue number3
DOIs
StatePublished - Sep 2014

Keywords

  • Abbreviations
  • CI
  • CTCAE
  • Common Terminology Criteria for Adverse Events
  • FCS
  • GI bleeding
  • GIB
  • HSCT
  • OR
  • PC
  • PPI
  • PRBC
  • SD
  • SSRI
  • confidence interval
  • fully conditional specification
  • hematopoietic stem cell transplantation
  • odds ratio
  • packed red blood cells
  • platelet count
  • proton pump inhibitor
  • selective serotonin reuptake inhibitor
  • standard deviation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

MD Anderson CCSG core facilities

  • Biostatistics Resource Group

Fingerprint

Dive into the research topics of 'Safety of endoscopic interventions in patients with thrombocytopenia'. Together they form a unique fingerprint.

Cite this